missing translation for 'onlineSavingsMsg'
Learn More

Ion Torrent™ Oncomine™ Comprehensive Assay Plus GX DNA

Product Code. 31034471
Change view
Click to view available options
Quantity:
16 Samples
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity
31034471 16 Samples
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 31034471 Supplier Ion Torrent™ Supplier No. A47015

Please to purchase this item. Need a web account? Register with us today!

Les retours ne sont pas autorisés pour ce produit. Afficher la politique du retour.

The Oncomine Comprehensive Assay Plus GX DNA is a targeted next-generation sequencing (NGS) assay that provides a comprehensive genomic profiling (CGP) solution appropriate for formalin-fixed paraffin-embedded (FFPE) tissues from solid tumors.

The Ion Torrent Oncomine Comprehensive Assay Plus GX DNA is a targeted next-generation sequencing (NGS) assay that provides a comprehensive genomic profiling (CGP) solution appropriate for formalin-fixed paraffin-embedded (FFPE) tissues from solid tumors. The assay detects a broad range of genomic alterations from 501 genes, including single-nucleotide variants (SNVs), insertions and deletions (indels), and copy number variations (CNVs) from DNA. Additionally, the assay detects genomic signatures such as homologous recombination deficiency (HRD) using genomic instability metric (GIM), tumor mutational burden (TMB), and microsatellite instability (MSI). This assay is the DNA component of the Oncomine Comprehensive Assay Plus GX (Cat. No. A47013), which includes both DNA and RNA assays.

Key features of the assay include:

  • Enables CGP across 501 genes
  • Accurately detects SNVs, indels, and CNVs, including large genomic rearrangements (LGRs) in BRCA1 and BRCA2
  • Assesses for genomic signatures, including HRD, TMB, and MSI, to help maximize insights on the underlying oncogenic drivers
  • Provides robust performance from 30 ng of DNA from FFPE samples, including fine needle biopsies
  • Provides multiplex sequencing of up to four DNA samples with optional NTC on a GX7 Chip in a single run
  • System-installed assays preconfigured with settings optimized for specific applications and sample types
  • Requires as little as 10 minutes hands-on time per run for easy, automated workflows
  • Provides automated Nucleic Acid to Result workflow on the Genexus Integrated Sequencer with next-day results

When used with the Genexus Purification System and the Genexus Integrated Sequencer, sequential sample purification, library preparation, sequencing, and analysis allow for the reporting of next-day results. With just two user touchpoints and as little as 20 minutes of hands-on time, the easy, automated workflows can help reduce handling errors, free up time for your laboratory staff, and reduce labor costs. As a single vendor of sample-to-report solutions, including instruments, consumables, analysis, and support, Thermo Fisher Scientific simplifies bringing in-house CGP to your lab at varying levels of NGS expertise.

TRUSTED_SUSTAINABILITY

Spécification

Sample Type DNA from FFPE
Sequencing Type Next Generation Sequencing
For Use With (Equipment) Genexus™ Integrated Sequencer
Product Type Oncomine Comprehensive Assay Plus GX DNA
Quantity 16 Samples

For Research Use Only. Not for use in diagnostic procedures.

Nom du produit
Sélectionnez un problème

En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.